GOREVIC JASON N 4
4 · Teladoc Health, Inc. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Gorevic Jason N
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2024-03-01+2,915→ 625,779 total - Exercise/Conversion
Common Stock
2024-03-01+5,615→ 637,176 total - Exercise/Conversion
Common Stock
2024-03-01+62,004→ 699,180 total - Exercise/Conversion
Common Stock
2024-03-01+7,648→ 706,828 total - Sale
Common Stock
2024-03-04$14.52/sh−53,755$780,308→ 653,073 total - Award
Performance Stock Units
2024-03-01+63,393→ 63,393 total→ Common Stock (63,393 underlying) - Exercise/Conversion
Performance Stock Units
2024-03-01−21,130→ 42,263 total→ Common Stock (21,130 underlying) - Exercise/Conversion
Common Stock
2024-03-01+21,130→ 622,864 total - Exercise/Conversion
Common Stock
2024-03-01+5,782→ 631,561 total - Exercise/Conversion
Performance Stock Units
2024-03-01−2,915→ 0 total→ Common Stock (2,915 underlying) - Exercise/Conversion
Performance Stock Units
2024-03-01−5,782→ 0 total→ Common Stock (5,782 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-01−5,615→ 22,460 total→ Common Stock (5,615 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-01−62,004→ 124,008 total→ Common Stock (62,004 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-01−7,648→ 0 total→ Common Stock (7,648 underlying)
Footnotes (12)
- [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F10]On March 1, 2022, the reporting person was granted 67,376 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F11]On March 3, 2023, the reporting person was granted 186,012 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F12]On March 2, 2021, the reporting person was granted 22,944 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
- [F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- [F4]Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
- [F5]Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
- [F6]The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F7]On March 1, 2024, the reporting person earned 63,393 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F8]On March 2, 2023, the reporting person earned 5,828 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.
- [F9]On March 2, 2022, the reporting person earned 17,346 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.